Teijin Limited

Juridical Foundation the Chemo-Sero-Therapeutic Research Institute

Nintendo Co., Ltd.

Asahi Glass Company, Limited

Nordson Corporation

Agc Inc.

Hal Laboratory, Inc.

Kenichi Masuda

Takashi Kamimura

Takashi Sugiyama

Kazuyoshi Yamaoka

Eiko Ohtsuka

Tetsuya Suga

Toshiaki Suzuki

Hiroshi H Eguchi

Makoto Fujii

Yoji Suzuki

Satoshi Kanasugi

Atsushi Imaizumi

Takanori Fukushi

Susumu Yasuoka

Takayoshi Hamamoto

Kenichiro Takagi

Hiroshi Yonemura

Masahiro Okada

Yoshitaka Tajima

Keishin Sugawara

Kazuyuki Nakashima

Yohichi Matsumoto

Yoshinori Sugimoto

Akiko Takeuchi

Kunihito Watanabe

Shiro Funatsu

Hiroko Ogawa

Takashi Watanabe

Naoki Hashitani

Akihiro Imura

Hideo Inoue

Izumi Mimaki

Masashi Sakurazawa

Shigeki Kasahara

A plate-like glass includes a chemically strengthened glass having a first surface, a second surface facing the first surface, and an end surface connecting the first surface and second surface. When a tangential direction from an arbitrary point on the first surface is assumed to be an X-axis, a direction orthogonal to the X-axis is assumed to be a Y-axis, and a direction orthogonal to the X-axis and the Y-axis is assumed to be a Z-axis, the X-axis is a direction in which a first curvature radius Rin cross-section of the first surface in an XZ plane passing the X-axis and Z-axis is minimum. The first surface has a curvature part in which the surface is bent in the X-axis direction on the first surface and the first curvature radius Ris within a specific range.

Curved surface cover glass, method for manufacturing same, and in-vehicle display member

An example information processing device displays a partial area of a panoramic video on a display device. The information processing device determines a display range of the panoramic video to be displayed on the display device based on an input made on a predetermined input device. A range and/or a position on a panoramic image is set as a target. Then, the information processing device displays the panoramic video of the display range on the display device, and outputs guide information representing a relationship between the display range and the target.

Storage medium storing information processing program, information processing device, information processing system, and panoramic video display method

A molding apparatus for glass molded product includes a mold, a press shaft and a release device. The release device includes a release member, a push bar, and a release action mechanism. The release member has a lower end surface to face an outer peripheral portion of a molding surface of the lower die of the mold. The push bar adjusts a downward pressure given to the release member. The release action mechanism is provided to hold an upper portion of the push bar movably along a shaft direction of the press shaft. The release action mechanism moves the push bar and the release member downward along the shaft direction to release a glass material and the upper die of the mold when the upper die and the lower die are separated after the glass material has been pressed between the upper die and the lower die.

Molding apparatus for glass molded product

A method for predicting the constitution susceptible to the onset of specific diseases in individual humans, for example, respiratory diseases such as chronic obstructive pulmonary diseases, sinobronchial syndrome, pulmonary emphysema, diffuse panbronchiolitis or bronchiectasis, effects of treatment on patients or prognosis of the treatment by analyzing the genetic polymorphisms of a human trypsin-like enzyme of the respiratory tract.

Analysis of predisposition based on human airway trypsin protease gene polymorphism

The present invention provides an elastase inhibitory polypeptide comprising a C-terminal half of a human secretory leukocyte protease inhibitor (SLPI) and having an elastase inhibitory activity wherein inhibitory activity of a trypsin-like serine protease does not exceed 1/10 of elastase inhibitory activity, and polypeptides having the above-mentioned biological activity wherein one or more than one amino acid is added, one or more than one amino acid is deleted and/or one or more than one amino acid is replaced. The present invention also provides a process for the production of the above-mentioned protein or other protein via a corresponding fused protein.

Elastase inhibitory polypeptide and process for production thereof by

This invention provides a nucleic acid sequence encoding a trypsin-like enzyme which can be present at the trachea of human lungs, and can selectively digest a synthetic substrate for trypsin and a synthetic substrate for thrombin, and fibrinogen; and a process for producing the trypsin-like enzyme by genetic engineering utilizing the nucleic acid sequence.

Nucleic acid sequence encoding trypsin-like enzyme and process for

A plasmid for expression of human coagulation factor VIII H-chain, a plasmid for expression of human coagulation factor VIII L-chain, an animal cell transformed with either said H-chain expression plasmid or said L-chain expression plasmid or with both thereof, and a process for preparing a human coagulation factor VIII protein complex which comprises forming a transformed animal cell by introducing both said H-chain expression plasmid and said L-chain expression plasmid into said animal cell, culturing said cell to produce the human coagulation factor VIII protein complex in the culture medium and collecting the same. The process of the present invention allows for the production of a safe factor VIII at a high expression level applicable for the production of Factor VIII on an industrial scale.

Process for preparing human coagulation factor VIII protein complex

Powder coating system for difficult to handle powders

A culture medium without or with a low level of protein for culturing a transformed animal cell capable of continuously producing a protein prepared by using a genetic engineering technique, which contains a nonionic surfactant and cyclodextrin, and a method for producing a protein which comprises culturing a transformed animal cell capable of producing the desired protein prepared by using a genetic engineering technique in the culture medium.

Culture medium for production of recombinant protein

Calcitonin derivatives wherein at least one of the first cysteine residue and the seventh cysteine residue is S-sulfonated; processes for the production of the calcitonin derivatives comprising the steps of reacting a calcitonin with a sulfite anion or both a sulfite anion and an oxidizing agent to form the S-sulfonated derivative, and recovering the sulfonated calcitonin derivative; a pharmaceutical composition comprising the S-sulfonated calcitonin derivative; and a method of treating a patient having a disease wherein a decrease of a serum calcium level is desired, by administering the S-sulfonated calcitonin derivative to the patient.

S-sulfonated calcitonin derivatives

Pyridopyrimidine nucleotide derivatives expressed by formula (I), which are fluorescent and capable of forming base pairing with guanine or adenine, and oligo- or polynucleotide which have at least one of these derivatives in their molecules or at their molecular terminals: ##STR1## wherein X.sub.1 and X.sub.1 respectively represent ##STR2## (in which n indicates an integer of 0, 1, 2, or 3; however, in no case X.sub.1 and Y.sub.1 both indicate n=O); Z.sub.1 indicates a hydrogen atom or ##STR3## (in which n indicates an integer of 1, 2, or 3); W.sub.1 indicates a hydrogen atom or a hydroxyl group. As for R.sub.1 and R.sub.2, in case where R.sub.1 is an amino group or halogen, R.sub.2 indicates a single bond between the carbon atom at the 7-position and the nitrogen atom at the 8-position, and in case where R.sub.2 is a hydrogen atom or an lower alkyl group, R.sub.1 indicates a carbonyl bond ##STR4## formed with the carbon atom at the 7-position.

Pyridopyrimidine nucleotide compounds

Growing community of inventors

Tokyo, Japan

Kenichi Masuda